Rang	Name	Position
1	Mr. Kyle W. Gano Ph.D.	President, CEO & Director
2	Mr. Matthew C. Abernethy CPA	Chief Financial Officer
3	Dr. Jude Onyia Ph.D.	Chief Scientific Officer
4	Mr. Eric S. Benevich	Chief Commercial Officer
5	Dr. Eiry Wyn Roberts M.D.	Strategic Advisor
6	Dr. Sanjay Keswani B.Sc., M.D., MBBS	Chief Medical Officer
7	Dr. Wylie W. Vale Ph.D.	Co-Founder
8	Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder of Neurocrine
9	Mr. Aaron Vosburgh	Senior Vice President of Finance & Accounting
10	Mr. Lewis Choi	Chief Information Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	13,17%	2,09 Mrd. USD
2	Dodge & Cox	5,49%	0,87 Mrd. USD
3	JPMorgan Chase & Co	5,35%	0,85 Mrd. USD
4	AQR Capital Management LLC	4,86%	0,77 Mrd. USD
5	Vanguard Portfolio Management, LLC	4,65%	0,74 Mrd. USD
6	Vanguard Capital Management, LLC	4,44%	0,71 Mrd. USD
7	State Street Corp	4,28%	0,68 Mrd. USD
8	Renaissance Technologies Corp	2,38%	0,38 Mrd. USD
9	Geode Capital Management, LLC	2,10%	0,33 Mrd. USD
10	Two Sigma Investments LLC	2,04%	0,32 Mrd. USD
11	BNP Paribas Investment Partners SA	1,47%	0,23 Mrd. USD
12	Vestal Point Capital LP	1,23%	0,20 Mrd. USD
13	Northern Trust Corp	1,22%	0,19 Mrd. USD
14	UBS Group AG	1,20%	0,19 Mrd. USD
15	Morgan Stanley - Brokerage Accounts	1,20%	0,19 Mrd. USD
16	RTW INVESTMENTS, LLC	1,04%	0,17 Mrd. USD
17	NORGES BANK	0,96%	0,15 Mrd. USD
18	First Trust Advisors L.P.	0,91%	0,14 Mrd. USD
19	Charles Schwab Investment Management Inc	0,89%	0,14 Mrd. USD
20	IEQ CAPITAL, LLC	0,75%	0,12 Mrd. USD